1
|
Kazaure HS, Roman SA and Sosa JA:
Medullary thyroid microcarcinoma: A population-level analysis of
310 patients. Cancer. 118:620–627. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen H, Sippel RS, O'Dorisio MS, Vinik AI,
Lloyd RV and Pacak K; North American Neuroendocrine Tumor Society
(NANETS), : The North American Neuroendocrine Tumor Society
consensus guideline for the diagnosis and management of
neuroendocrine tumors: Pheochromocytoma, paraganglioma, and
medullary thyroid cancer. Pancreas. 39:775–783. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Dequanter D and Lothaire P: Medullary
thyroid cancer: Surgical results and prognostic factors. Rev Med
Liege. 65:450–452. 2010.(In French). PubMed/NCBI
|
4
|
Skinner MA, Moley JA, Dilley WG, Owzar K,
Debenedetti MK and Wells SA Jr: Prophylactic thyroidectomy in
multiple endocrine neoplasia type 2A. N Engl J Med. 353:1105–1113.
2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lee CR, Lee S, Son H, Ban E, Kang SW, Lee
J, Jeong JJ, Nam KH, Chung WY and Park CS: Medullary thyroid
carcinoma: a 30-year experience at one institution in Korea. Ann
Surg Treat Res. 91:278–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sionov RV, Assi S, Gershkovitz M, Sagiv
JY, Polyansky L, Mishalian I, Fridlender ZG and Granot Z: Isolation
and characterization of neutrophils with anti-tumor properties. J
Vis Exp: e52933. 2015. View
Article : Google Scholar
|
7
|
Sionov RV, Fridlender ZG and Granot Z: The
multifaceted roles neutrophils play in the tumor microenvironment.
Cancer Microenviron. 8:125–158. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tecchio C and Cassatella MA:
Neutrophil-derived cytokines involved in physiological and
pathological angiogenesis. Chem Immunol Allergy. 99:123–137. 2014.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Jiang K, Lei J, Chen W, Gong Y, Luo H, Li
Z, Gong R and Zhu J: Association of the preoperative
neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with
lymph node metastasis and recurrence in patients with medullary
thyroid carcinoma. Medicine (Baltimore). 95:e50792016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Giraldo NA, Becht E, Vano Y,
Sautès-Fridman C and Fridman WH: The immune response in cancer:
From immunology to pathology to immunotherapy. Virchows Arch.
467:127–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Jiang K, Lei J, Li C, Shu K, Li W, Zhang
Y, Li Z, Gong R and Zhu J: Comparison of the prognostic values of
selected inflammation based scores in patients with medullary
thyroid carcinoma: A pilot study. J Surg Oncol. 116:281–287. 2017.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Yu Y, Wang H, Yan A, Wang H, Li X, Liu J
and Li W: Pretreatment neutrophil to lymphocyte ratio in
determining the prognosis of head and neck cancer: A meta-analysis.
BMC Cancer. 18:3832018. View Article : Google Scholar : PubMed/NCBI
|
13
|
Brücher BL and Jamall IS: Epistemology of
the origin of cancer: A new paradigm. BMC Cancer. 14:3312014.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Kim S, Miller BJ, Stefanek ME and Miller
AH: Inflammation-induced activation of the indoleamine
2,3-dioxygenase pathway: Relevance to cancer-related fatigue.
Cancer. 121:2129–2136. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hainaut P and Plymoth A: Targeting the
hallmarks of cancer: Towards a rational approach to next-generation
cancer therapy. Curr Opin Oncol. 25:50–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Liu JF, Ba L, Lv H, Lv D, Du JT, Jing XM,
Yang NJ, Wang SX, Li C and Li XX: Association between
neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: A
meta-analysis. Sci Rep. 6:385512016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kocer D, Karakukcu C, Karaman H, Gokay F
and Bayram F: May the neutrophil/lymphocyte ratio be a predictor in
the differentiation of different thyroid disorders? Asian Pac J
Cancer Prev. 16:3875–3879. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Taguchi S, Nakagawa T, Matsumoto A, Nagase
Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, et
al: Pretreatment neutrophil-to-lymphocyte ratio as an independent
predictor of survival in patients with metastatic urothelial
carcinoma: A multi-institutional study. Int J Urol. 22:638–643.
2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Huang C, Yue J, Li Z, Li N, Zhao J and Qi
D: Usefulness of the neutrophil-to-lymphocyte ratio in predicting
lymph node metastasis in patients with non-small cell lung cancer.
Tumour Biol. 36:7581–7589. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chen J, Hong D, Zhai Y and Shen P:
Meta-analysis of associations between neutrophil-to-lymphocyte
ratio and prognosis of gastric cancer. T World J Surg Oncol.
13:1222015. View Article : Google Scholar
|
21
|
Choi WJ, Cleghorn MC, Jiang H, Jackson TD,
Okrainec A and Quereshy FA: Preoperative neutrophil-to-lymphocyte
ratio is a better prognostic serum biomarker than
platelet-to-lymphocyte ratio in patients undergoing resection for
nonmetastatic colorectal cancer. Ann Surg Oncol. 22 Suppl
3:S603–S613. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wells SA Jr, Asa SL, Dralle H, Elisei R,
Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, et al:
Revised American Thyroid Association guidelines for the management
of medullary thyroid carcinoma. Thyroid. 25:567–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC
and Cheng SP: Blood neutrophil-to-lymphocyte ratio correlates with
tumor size in patients with differentiated thyroid cancer. J Surg
Oncol. 107:493–497. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hazard JB, Hawk WA and Crile G Jr:
Medullary (solid) carcinoma of the thyroid; a clinicopathologic
entity. J Clin Endocrinol Metab. 19:152–161. 1959. View Article : Google Scholar : PubMed/NCBI
|
25
|
Yamazaki M, Straus FH, Messina M, Robinson
BG, Takeda T, Hashizume K and DeGroot LJ: Adenovirus-mediated
tumor-specific combined gene therapy using Herpes simplex virus
thymidine/ganciclovir system and murine interleukin-12 induces
effective antitumor activity against medullary thyroid carcinoma.
Cancer Gene Ther. 11:8–15. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Hyer SL, Vini L, A'Hern R and Harmer C:
Medullary thyroid cancer: Multivariate analysis of prognostic
factors influencing survival. Eur J Surg Oncol. 26:686–690. 2000.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Costante G, Meringolo D, Durante C,
Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M,
Torlontano M and Filetti S: Predictive value of serum calcitonin
levels for preoperative diagnosis of medullary thyroid carcinoma in
a cohort of 5817 consecutive patients with thyroid nodules. J Clin
Endocrinol Metab. 92:450–455. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
de Groot JW, Plukker JT, Wolffenbuttel BH,
Wiggers T, Sluiter WJ and Links TP: Determinants of life expectancy
in medullary thyroid cancer: Age does not matter. Clin Endocrinol
(Oxf). 65:729–736. 2006. View Article : Google Scholar : PubMed/NCBI
|
29
|
De Santis E, Di Vito M, Perrone GA, Mari
E, Osti M, De Antoni E, Coppola L, Tafani M, Carpi A and Russo MA:
Overexpression of pro-inflammatory genes and down-regulation of
SOCS-1 in human PTC and in hypoxic BCPAP cells. Biomed
Pharmacother. 67:7–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Guarino V, Castellone MD, Avilla E and
Melillo RM: Thyroid cancer and inflammation. Mol Cell Endocrinol.
321:94–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Malietzis G, Giacometti M, Askari A,
Nachiappan S, Kennedy RH, Faiz OD, Aziz O and Jenkins JT: A
preoperative neutrophil to lymphocyte ratio of 3 predicts
disease-free survival after curative elective colorectal cancer
surgery. Ann Surg. 260:287–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Feng JF, Huang Y, Zhao Q and Chen QX:
Clinical significance of preoperative neutrophil lymphocyte ratio
versus platelet lymphocyte ratio in patients with small cell
carcinoma of the esophagus. ScientificWorldJournal.
2013:5043652013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim
KH and Kim HJ: Prognostic significance of neutrophil lymphocyte
ratio and platelet lymphocyte ratio in advanced gastric cancer
patients treated with FOLFOX chemotherapy. BMC Cancer. 13:3502013.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Basuyau JP, Mallet E, Leroy M and Brunelle
P: Reference intervals for serum calcitonin in men, women, and
children. Clin Chem. 50:1828–1830. 2004. View Article : Google Scholar : PubMed/NCBI
|
35
|
Boschin IM, Torresan F, Toniato A, Zane M,
Ide EC, Pennelli G, Rampin L, Colletti PM, Rubello D and Pelizzo
MR: Incidental medullary thyroid microcarcinoma revealed by mild
increase of preoperative serum calcitonin levels: Therapeutic
implications. Endocrine. 45:448–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Saltiki K, Rentziou G, Stamatelopoulos K,
Georgiopoulos G, Stavrianos C, Lambrinoudaki E and Alevizaki M:
Small medullary thyroid carcinoma: Post-operative calcitonin rather
than tumour size predicts disease persistence and progression. Eur
J Endocrinol. 171:117–126. 2014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Kihara M, Miyauchi A, Kudo T, Hirokawa M
and Miya A: Reference values of serum calcitonin with calcium
stimulation tests by electrochemiluminescence immunoassay
before/after total thyroidectomy in Japanese patients with thyroid
diseases other than medullary thyroid carcinoma. Endocr J.
63:627–632. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Romero-Lluch AR, Cuenca-Cuenca JI,
Guerrero-Vázquez R, Martínez-Ortega AJ, Tirado-Hospital JL,
Borrego-Dorado I and Navarro-González E: Diagnostic utility of
PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent
medullary thyroid carcinoma: The importance of calcitonin and
carcinoembryonic antigen cutoff. Eur J Nucl Med Mol Imaging.
44:2004–2013. 2017. View Article : Google Scholar : PubMed/NCBI
|